MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Social Network for the diagnosis of RLS

C. Guerra-Galicia, J. Blanco-Galina (San Luis Potosí, Mexico)

Meeting: 2019 International Congress

Abstract Number: 578

Keywords: Restless legs syndrome(RLS): Clinical features, Restless legs syndrome(RLS): Treatment

Session Information

Date: Monday, September 23, 2019

Session Title: Restless Leg Syndrome, RBD and Other Sleep Disorders

Session Time: 1:45pm-3:15pm

Location: Les Muses Terrace, Level 3

Objective: Identify patients with RLS using social media, describe time of evolution, previous diagnosis, treatment, symptoms severity and quality of life perception.

Background: RLS is a rest-induced, movement-responsive, mostly nocturnal, urge to move the legs, with a prevalence of 4 to 29%. According to the REST study, 5% of adults have RLS symptoms at least once a week. Altough several epidemiologic studies report RLS as one of the most common movement disorders in clinical practice, it is commonly under-diagnosed by general practicioners and specialists. It can be misdiagnosed as arthritis, depression, anxiety, parasites, stress, psychogenic, etc. It has a significant socio-economic impact and low quality of life.

Method: We published the Single Question for RLS (Ferri et al, 2007) on Facebook for 24 hours. Patients with affirmative responses were  evaluated by a movement disorders specialists, to confirm diagnosis, define the severity of symptoms and assess quality of life. Demographic data, time of symptoms evolution, previous diagnosis and treatment data were collected.

Results: 37% subjects responded affirmatively the Single Question in 24 hours (19 out of 51). 73.6% were female, mean age 31.7 years old (33.7 years old for men). All subjects were economically active, with at least one college degree and with negative past medical history. 18 patients were confirmed to have RLS after MD-specialists consult. All of the RLS confirmed subjects had previously reported leg symptoms to their physician at least 4 times, mean time of evolution of 4.7 years prior to our study. 63% of them were treated by a family physician, 15.7% by a psychiatrist, and 26% by other physician (neurologists, gynecologist and internal medicine specialists). None of them were diagnosed with RLS. 88% of them had moderate to severe symptoms, and 75% considered to have a negative impact in their QoL. Common diagnosis were anxiety (46%), arthritis (30%), polyneuropathy (16%) and muscle cramps (8%). Benzodiazepines were the most frequently single prescribed drug (73%) followed by pregabalin (20%) and vitamins (7%). 45% of the subjects were under two drugs, ISRS/TCA with benzodiazepines. Only 16% of the subjects considered to have a good control of their symptoms.

Conclusion: Social networks can be an easy way to detect RLS patients, it can alse be used to screen under-diagnosed diseases, helping patients to reach an appropiate diagnosis and treatment, and, hopefully, improve their QoL perception.

To cite this abstract in AMA style:

C. Guerra-Galicia, J. Blanco-Galina. Social Network for the diagnosis of RLS [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/social-network-for-the-diagnosis-of-rls/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/social-network-for-the-diagnosis-of-rls/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley